Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay CTA Index down -1.81 in June on ECB meeting, (+ 0.03% YTD)

Tuesday, July 17, 2012
Opalesque Industry Update: Managed futures lost 1.81% overall in June according to the Barclay CTA Index compiled by BarclayHedge. The Index is up 0.03% year to date.

“The month-end ECB agreement to make loans directly to eurozone banks drove prices in some of the major equity, currency, and commodity markets to their largest one-day moves of the year,” says Sol Waksman, founder and president of BarclayHedge.

On the negative side, Barclay Diversified Traders Index fell 2.89% in June, Systematic Traders lost 2.51%, and Financial & Metals Traders were down 0.56%.

“Momentum-based trend following traders typically take losses when markets reverse course sharply,” says Waksman.

On the positive side, Agricultural Traders gained 3.45% in June, and Discretionary Traders were up 1.40%.

“Drought fears in the US drove prices higher for agricultural commodities,” says Waksman.

After six months in 2012, the Barclay Agricultural Traders Index leads all managed futures strategies with a gain of 4.73%. Currency Traders are up 1.19% year to date, and Discretionary Traders have gained 0.84%.

The Diversified Traders Index is down 1.45% after two quarters, Financial & Metals Traders have lost 0.94%, and Systematic Traders gave up 0.81%.

The Barclay BTOP50 Index, which measures performance of the largest CTAs, was down 1.50% in June. The BTOP50 was up 0.09% through June 2012.

BarclayHedge

Press Release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its